Patent details
EP1250146 Title: USE OF BOTULINUM TOXINS FOR TREATING DIABETES
Basic Information
- Publication number:
- EP1250146
- PCT Application Number:
- PCT/US/2001/002273
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP019032622
- PCT Publication Number:
- WO/2001/054711
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF BOTULINUM TOXINS FOR TREATING DIABETES
- French Title of Invention:
- UTILISATION DE TOXINES BOTULINUM DANS LE TRAITEMENT DU DIABETE
- German Title of Invention:
- VERWENDUNG VON BOTULINUM-TOXIN ZUR BEHANDLUNG VON DIABETES
- SPC Number:
Dates
- Filing date:
- 24/01/2001
- Grant date:
- 02/01/2004
- EP Publication Date:
- 02/01/2004
- PCT Publication Date:
- 02/08/2001
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 23/10/2002
- EP B1 Publication Date:
- 02/01/2004
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 24/01/2004
- Expiration date:
- 24/01/2021
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 24/01/2001
- Name:
- Allergan Inc.
- Address:
- 2525 Dupont Drive,, Irvine, CA 92612, United States (US)
Inventor
- Name:
- DONOVAN Stephen
- Address:
- United States (US)
Priority
- Priority Number:
- 491420
- Priority Date:
- 26/01/2000
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 38/16;
| Filing date | Document type | Number of pages |
|---|